NME1 and melanoma: These considerations suggested the hypothesis that reduced NME1 expression in melanoma cells not only confers increased metastatic activity, but also enhanced genomic stability via downregulation of the low fidelity A-NHEJ pathway and upregulation of the higher fidelity HR and C-NHEJ pathways.